Replies to post #746833 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Final Estimate: Baseline Estimate: $4M–$8M in damages. If Treble Damages Apply: $12M–$24M in potential recovery.

Market makers (Citadel, etc.) might settle rather than go to trial. In that case between $1 to $1.5 per share isn't that far off.

Last I checked NWBO has 1.3B shares outstanding,so $12-24M is about 1-2 cents a share.

And I do not accept your assertions about NWBO's historical price. It was clearly under .25 for most of the transactions. That is in the complaint.